Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Idiopathic Pulmonary Fibrosis (IPF): early-phase trial registry
7 of 9 indexed Idiopathic Pulmonary Fibrosis (IPF) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 7 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Idiopathic Pulmonary Fibrosis (IPF): 9 US clinical trials tracked, 7 recruiting.
Idiopathic Pulmonary Fibrosis (IPF) is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Rein Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition idiopathic-pulmonary-fibrosis-ipf
OPEN 7 | RECR 78% | LATE 0 | EARLY 7 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Colorectal Carcinoma (78% recruiting · 9 trials)
Idiopathic Pulmonary Fibrosis (IPF) lists 7 open slots (78% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Idiopathic Pulmonary Fibrosis (IPF) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Idiopathic Pulmonary Fibrosis (IPF) is recruiting above its size-band peers.
7 of 9 indexed trials (77.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Idiopathic Pulmonary Fibrosis (IPF) trials is spread across many organizations.
Rein Therapeutics accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Idiopathic Pulmonary Fibrosis (IPF) enrolment sits around 120 participants.
Median target enrolment is 120 among the 9 trials that report a genuine target (sentinel values excluded). 4 of those (44.4%) plan for fewer than 100 participants.
-
Idiopathic Pulmonary Fibrosis (IPF) research is mostly interventional.
7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Weill Medical College of Cornell University
NCT01776398
The Genetics of Pulmonary Fibrosis
University of Colorado, Denver
NCT03478553
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Vicore Pharma AB
NCT06588686
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Avalyn Pharma
NCT06951217
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Rein Therapeutics
NCT06968845
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
InSilico Medicine Hong Kong Limited
NCT05975983
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis
Mannkind Corporation
NCT07344558
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
National Jewish Health
NCT04598919
STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Biogen
NCT01371305
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Idiopathic Pulmonary Fibrosis (IPF) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Idiopathic Pulmonary Fibrosis (IPF) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Idiopathic Pulmonary Fibrosis (IPF) page
9 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Idiopathic Pulmonary Fibrosis (IPF) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Rein Therapeutics sponsors the most Idiopathic Pulmonary Fibrosis (IPF) trials on record, review their full trial history before evaluating a specific study. See Rein Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Idiopathic Pulmonary Fibrosis (IPF) condition card totals 9 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.